Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Teva
Daiichi Sankyo
Mallinckrodt
Fuji
Farmers Insurance
Federal Trade Commission
Dow

Generated: December 11, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,469,030

« Back to Dashboard

Which drugs does patent 6,469,030 protect, and when does it expire?

Patent 6,469,030 protects ENTEREG and is included in one NDA.

This patent has nineteen patent family members in fourteen countries.

Summary for Patent: 6,469,030
Title: Methods for the treatment and prevention of ileus
Abstract:Methods for the treatment and/or prevention of ileus are disclosed. The methods comprise administering to a patient an effective amount of a peripheral mu opioid antagonist compound. Preferred compounds for use in the methods include piperidine-N-alkylcarboxylates.
Inventor(s): Farrar; John J. (Chester Springs, PA), Schied; Peter J. (Southampton, PA), Schmidt; William K. (Newark, DE), Carpenter; Randall L. (Waban, MA)
Assignee: Adolor Corporation (Exton, PA)
Application Number:09/725,708
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,469,030

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cubist Pharms ENTEREG alvimopan CAPSULE;ORAL 021775-001 May 20, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial A METHOD OF TREATING OR PREVENTING ILEUS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,469,030

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 432076 ➤ Try a Free Trial
Australia 2005203041 ➤ Try a Free Trial
Australia 3970501 ➤ Try a Free Trial
Australia 780738 ➤ Try a Free Trial
Canada 2393141 ➤ Try a Free Trial
Cyprus 1109264 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Cerilliant
Harvard Business School
QuintilesIMS
US Army
McKinsey
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.